chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Oropharyngeal pain, Rash, Vomiting
Clinical narrative: chills; sweating; dizziness; headache; head rash; general tiredness/bad lethargy/ more tired; muscle aches; Nausea/ sick to her stomach; Vomiting/ throwing up; sore throat; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on 15Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Jan2021, the patient was having side effects like vomiting, sore throat, sweating, dizziness, head rash, general tiredness, muscle aches, and nausea, the patient was wondering if she can go to the hospital. She got her vaccine on 15Jan2021 and had a tiny reaction right away that went away in 20 minutes; sweating, dizziness and a headache. After that she felt a little more tired than usual, but it has progressed more and more everyday; she has been more and more tired. On 22Jan2021 she had some chills, and was feeling a little worse and worse, then yesterday she had a headache and a little bit of a sore throat. Stated that she went home from work yesterday and went right to bed at 2pm because she was so tired. Today, she woke up again really tired but went in to work, and then this after she got so sick to her stomach and started throwing up. Now, she can't keep anything down. Stated that she just kept feeling worse and worse. "Is this Covid? Or is it from the vaccine?" It was starting to scare her. It felt like she almost has food poisoning at this point, but with really bad lethargy, a headache, and really bad chills. Outcome of the events sweating and dizziness was recovered on 15Jan2021, while unknown for the other events.   Information on the lot/batch number has been requested.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Mild tingle in tip of tongue 30 minutes after injection; This is a spontaneous report from a contactable 43-year-old male consumer reported for himself who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL9261/expiration date: unknown), via unknown route of administration, on 21Jan2021 07:45 AM (at the age of 43 years old) as a single dose on left arm for COVID-19 immunisation at a hospital. Relevant medical history included and concomitant medications were not provided. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 21Jan2021 at 08:15 AM, the patient stated that he experienced mild tingle in tip of tongue 30 minutes after injection. The patient received no treatment for the event. The outcome of the event  "mild tingle in tip of tongue 30 minutes after injection" was recovered. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Body aches; Fever; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a female patient (Daughter)   A female patient of unspecified age received first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on an unspecified date  at single dose via an unspecified route of administration  for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. Reporter mentioned that her daughter got the vaccine and on an unspecified date had body aches and fever. It was also informed that patient had symptoms like covid, and reporter also asked if her daughter was now positive with Covid after the first dose (as such). At the time of the reporting event outcome was unknown.   Information on the Lot/Batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: muscle pain; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. After the first dose, on an unspecified date, the patient experienced muscle pain. The patient will go to the doctor because of her experience. The patient also had questions about how long the vaccine will protect her from the virus. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at injection site; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient not pregnant received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Right arm on 20Jan2021 at 02:45 PM as a single dose for COVID-19 immunisation, lot number: unknown. Medical history was not provided. Patient had no allergies to medications, food, or other products. Prior to vaccination the patient was not diagnosed with COVID-19. Concomitant medications in two weeks prior to the vaccination included cetirizine hydrochloride (ZYRTEC ALLERGY), curcuma zanthorrhiza (CURCUMEN TUERMERIC), ubidecarenone (CO-ENZYME Q10) and Beet roo (as reported). Patient did not receive other vaccine in four weeks prior to the COVID vaccine. On 21Jan2021 at 06:15 AM patient experienced pain at injection site when she woke up this morning which had lasted through the day. No treatment was received for the event. Since the vaccination patient had not been tested for COVID-19. Patient had not recovered from the event, at the time of the report.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: A little bit dizzy; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on 20Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first shot today 20Jan2021. She was a little bit dizzy but okay now. Wanting to know if I'm okay to have a congratulatory champagne. Outcome of the event was recovered on 20Jan2021.   Information about lot/batch number has been requested.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Body temperature, Chills, Feeling abnormal, Feeling cold
Clinical narrative: delirious dreams; extreme chills; so cold that it felt like burning ice cubes on skin, could not get warm even with multiple blankets; severe body aches; severe headache; fever of 101; nausea; thirsty; Symptoms began to abate today (almost 48 hours later) but still fet some foggy thinking; This is a spontaneous report from a contactable other health care professional (patient) and a contactable consumer.  A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELIZ83), via an unspecified route of administration at arm left on 19Jan2021 at single dose for COVID-19 immunization. The patient medical history included hypothyroidism from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient previously received fist dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) via an unspecified route of administration at arm left on 29Dec2020 at 9:30 at single dose for COVID-19 immunization.   On Jan2021, the patient reported that 15 hours after second dose, he experienced extreme chills, so cold that it felt like burning ice cubes on his skin, he couldn't get warm even with multiple blankets, severe body aches, fever of 101 F, severe headache, delirious dreams, nausea, thirsty and feel some foggy thinking. The patient outcome of the event was recovering.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia, Thirst
Clinical narrative: delirious dreams; extreme chills; so cold that it felt like burning ice cubes on skin, could not get warm even with multiple blankets; severe body aches; severe headache; fever of 101; nausea; thirsty; Symptoms began to abate today (almost 48 hours later) but still fet some foggy thinking; This is a spontaneous report from a contactable other health care professional (patient) and a contactable consumer.  A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELIZ83), via an unspecified route of administration at arm left on 19Jan2021 at single dose for COVID-19 immunization. The patient medical history included hypothyroidism from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient previously received fist dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) via an unspecified route of administration at arm left on 29Dec2020 at 9:30 at single dose for COVID-19 immunization.   On Jan2021, the patient reported that 15 hours after second dose, he experienced extreme chills, so cold that it felt like burning ice cubes on his skin, he couldn't get warm even with multiple blankets, severe body aches, fever of 101 F, severe headache, delirious dreams, nausea, thirsty and feel some foggy thinking. The patient outcome of the event was recovering.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Fever; Chills; Headache; Muscle aches; Injection site burning and soreness for 36 hours; This is a spontaneous report from a contactable healthcare professional (the patient).  A 26-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EL9262), intramuscular in the left arm on 20Jan2021 10:30 (at the age of 26-years-old) as a single dose for COVID-19 immunization. Medical history included asthma, and the patient was diagnosed with COVID-19 prior to vaccination. The patient did not have any allergies to medications, food, or other products. The patient did not have any concomitant medications. The patient had not received any other vaccine within 4 weeks prior to the vaccine. On 21Jan2021, the patient experienced fever, chills, headache, muscle aches, injection site burning and soreness for 36 hours (as reported). The patient did not receive treatment for these events. The clinical outcome of fever, chills, headache, muscle aches, injection site burning and soreness was recovering (as reported). It was also reported that since the vaccination, the patient had not been tested for COVID-19.     No follow-up attempts are possible. No further information is expected
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes simplex, Pain, Vaccination site pain, Vaccination site swelling
Clinical narrative: Body aches, pain; pain and swelling at injection site; pain and swelling at injection site; HSV2 outbreaks; This is a spontaneous report from a nurse (patient herself). A 48-year-old female patient (not pregnant) received bnt162b2 (BNT162B2 also reported as COVID 19 vaccine, brand Pfizer), second dose in left arm on 13Jan2021 (lot EL1283) and first dose in right arm on 23Dec2020 09:15 (lot EK5730), via an unspecified route of administration at single dose, for Covid-19 immunisation. Medical history was none. No any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included colecalciferol (VITAMIN D). On 15Jan2021 20:00, she had body aches, pain and swelling at injection site and HSV2 outbreaks with both doses. First was more severe than the second and took longer to heal. No treatment was given. The outcome of events was recovered.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Herpes zoster, Pain, Pustule, Rash
Clinical narrative: Rash blisters with clear fluid forming on neck back and chest.; Rash blisters with clear fluid forming on neck back and chest.; Burning pain coming in waves pustules that were clear have ruptured and reformed. Went to doctor prescribed shingles medication and tramadol; Burning pain coming in waves pustules that were clear have ruptured and reformed. Went to doctor prescribed shingles medication and tramadol; prescribed shingles medication; This is a spontaneous report from a contactable other healthcare professional (patient). A 56-year-old male patient receive second single dose of BNT162B2 (Pfizer, Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration (vaccine location: Left arm) on 17Jan2021 13:15 for Covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered: Nursing Home/Senior Living Facility. There was no relevant medical history. Patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first single dose of BNT162B2 (Pfizer) on 27Dec2020 14:00, vaccine location: Left leg, for Covid-19 immunization. On 18Jan2021 06:00, the patient experienced rash blisters with clear fluid forming on neck, back, and chest. There was also burning pain coming in waves pustules that were clear have ruptured and reformed. Went to doctor wherein patient was prescribed shingles medication and tramadol. The events were considered as non-serious by the reporter. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient was recovering from pustule while the outcome of the other events was not recovered.  Information about lot number and expiry date for the suspect product will be requested in follow-up attempts.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: pain at injection site; fever; This is a spontaneous report from a non-contactable consumer.  An adult male patient received BNT162B2 (lot not available/provided) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient experienced pain at injection site and fever on unspecified dates. It was noted that it was forgotten if it was pain at injection site or fever the day after. The events were non-serious in which did not result in death, not life threatening, did not caused/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity
Clinical narrative: his wife had chills; she did feel pain; had a sore arm; This is a spontaneous report from a contactable Consumer (patient's husband). A 93-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had chills and feel pain and had a sore arm. Outcome of the events was unknown. Information on the lot/ batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Malaise, Myalgia
Clinical narrative: Joint pain; Fatigue; Headache; Pain and swelling at injection site; Pain and swelling at injection site; makes me feel sick/ malaise; Muscle pain; Nausea; Fever; This is a spontaneous report from a non-contactable nurse reporting for herself. A female patient of unspecified age received the second dose of BNT162B2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration, on 19Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (BNT162B2, lot number and expiry date were not reported), on an unspecified date for COVID-19 immunization. The patient experienced the following on an unspecified date in Jan2021 after her 2nd dose of COVID 19 vaccine: "This Covid 19 vaccine makes me feel sick. Experiencing the following after my second dose: Pain and swelling at injection site, Fatigue/ malaise, Headache, Muscle pain/ Joint pain, Fever, and Nausea." Outcome of the events was unknown.   No follow-up attempts are possible, information about batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination site pain, Vaccination site swelling
Clinical narrative: Joint pain; Fatigue; Headache; Pain and swelling at injection site; Pain and swelling at injection site; makes me feel sick/ malaise; Muscle pain; Nausea; Fever; This is a spontaneous report from a non-contactable nurse reporting for herself. A female patient of unspecified age received the second dose of BNT162B2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration, on 19Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (BNT162B2, lot number and expiry date were not reported), on an unspecified date for COVID-19 immunization. The patient experienced the following on an unspecified date in Jan2021 after her 2nd dose of COVID 19 vaccine: "This Covid 19 vaccine makes me feel sick. Experiencing the following after my second dose: Pain and swelling at injection site, Fatigue/ malaise, Headache, Muscle pain/ Joint pain, Fever, and Nausea." Outcome of the events was unknown.   No follow-up attempts are possible, information about batch number cannot be obtained.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Injection site pain; Arm pretty sore; This is a spontaneous report from a contactable physician who reported for himself. A 58-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot #: EJ1685) via an unspecified route of administration on 23Dec2020 at 09:00 (at the age of 58-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included a history of anaphylaxis to latex which predated treatment with the Pfizer COVID-19 vaccine, heart rate control, hypertension and high cholesterol; all from unspecified dates and unspecified if ongoing. It was also reported that the patient's medical history was "none" and that the patient had no illness at the time of vaccination. Family medical history was reported as "none". Concomitant medications included ongoing metoprolol taken for heart rate control taken from an unspecified date ("taking for two years"), ongoing telmisartan taken for hypertension orally from an unspecified date ("taking for two years") at 1x/day (take once daily by mouth) and ongoing rosuvastatin calcium (CRESTOR; strength: 40mg) taken for high cholesterol from an unspecified date ("taking for 10 years") at 40mg, 1x/day. The patient did not receive any additional vaccines on the same date of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Dec2020 the patient experienced "injection site pain" and "arm pretty sore". It was reported that "a physician called regarding the Pfizer COVID-19 vaccine. The patient reported that he received the second dose of the vaccine on Thursday and was advised by his medical director to call Pfizer to report his symptoms. He reported that he received the first dose of the Pfizer COVID-19 vaccine three weeks prior to the second dose. The patient first stated that was about 14Dec2020, but then clarified that per his vaccine card, he received the first dose of the vaccine on 23Dec2020 at 0900AM in the left arm. The patient stated that he noticed injection site pain that lasted about two days and his arm was pretty sore. Both events completely resolved before the second dose." It was reported that the events did not require a visit to the physician or to the ER. It was reported that there were no relevant tests. The clinical outcomes of the events "injection site pain" and "arm pretty sore" were both recovered/resolved on 15Jan2021.  The reporter considered that there was reasonable possibility (method of assessment: Global introspection) that the events "injection site pain" and "arm pretty sore" were related to BNT162B2.
Age: 95.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Laboratory test, Pain in extremity, Weight
Clinical narrative: My arm is little sore; This is a spontaneous report from a contactable consumer reporting for himself. A 95-years-old male patient received BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, via an unspecified route of administration on 20Jan2021 at single dose for COVID-19 immunization. The patient also received apixaban (ELIQUIS), 2 dose forms (DF) every day, via an unspecified route of administration from an unspecified date at an unknown dose as blood thinner. Medical history included a bone spur in the left foot that causes the patient to limp a bit, although he is still able to move around a little bit ("he is surprised that he is still plodding along"), cardiac pacemaker insertion, body weight sometimes increasing, a trouble with his vision, so he has a restricted driver's license: he can only drive during the day time. The patient is also a hearing aid user from an unknown date and has central nervous system stimulation from an unknown date ("I have Neuraxis"). His wife says that "he has them every day". Past drug history included warfarin sodium (COUMADIN) used for years as blood thinner. The patient's concomitant medications were not reported, although the patient stated he takes a lot of medications. The patient reported that the vaccine "worked beautifully", but only after the shot he could read on the information sheet that the he should have told the provider about all his medical conditions, if he has a bleeding disorder or is on a blood thinner. Now he's reluctant to take his pills because of this warning. He feels fine, he doesn't have any problems with the shot. He only stated that his arm was little sore but that's to be expected. The patient would like to know if he can continue to take his blood thinner. On an unknown date the patient underwent lab tests connected with some kind of surgery or his pacemaker whose results were unknown. The action taken with apixaban in response to the event was unknown. The event outcome was unknown at the time of the report.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph nodes along the collar bone; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female of unspecified age received bnt162b2 (reported as COVID-19 vaccine), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient received vaccine Friday (unspecified date) and had developed swollen lymph nodes along the collar bone on an unspecified date. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: body aches; incredible fatigue; headache; This is a spontaneous report from a contactable  health care professional nurse, the patient. A female patient (nurse) of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: unknown), via an unspecified route of administration on unspecified date  as a single dose,  for COVID-19 vaccination. The patient medical history and  concomitant medications were not reported. On an unspecified date, the patient experienced incredible fatigue, and body aches followed with a headache for about 24 hours. The clinical outcome of the events fatigue, body aches  and headache was unknown.   No follow-up attempts are possible; information about lot number cannot be obtained
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Musculoskeletal stiffness, Myalgia, Pain
Clinical narrative: muscle aches; Joint pain; Tingling; Fatigue; Little more stiff; sore than usual; This is a spontaneous report from a contactable nurse.  A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 and she had "incredible fatigue, and body aches followed with a headache" for about 24 hours.  Five hours after second dose, the patient experienced muscle aches, joint pain, tingling, and fatigue lasted about 30 hours- it has resolved just a little more stiff /sore than usual. The outcome of the events little more stiff, and sore was unknown while recovered for the other events.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: muscle aches; Joint pain; Tingling; Fatigue; Little more stiff; sore than usual; This is a spontaneous report from a contactable nurse.  A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 and she had "incredible fatigue, and body aches followed with a headache" for about 24 hours.  Five hours after second dose, the patient experienced muscle aches, joint pain, tingling, and fatigue lasted about 30 hours- it has resolved just a little more stiff /sore than usual. The outcome of the events little more stiff, and sore was unknown while recovered for the other events.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Patient reported a sore arm for 3 days; This is a spontaneous report from a contactable nurse. This nurse reported that a patient of unknown age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number/Exp. date unknown), via an unspecified route of administration on unknown date at single dose for an COVID-19 immunisation. The patient medical history and concomitant medications were not provided. The patient reported a sore arm for 3 days on unknown date after vaccination. The outcome of event sore arm was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Head discomfort, Malaise
Clinical narrative: Heavy headed (not headache); malaise; chills; This is a spontaneous report from a contactable nurse (patient). A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9261, expiry date unknown), intramuscular at the left arm on 20Jan2021, 11:30 at single dose for COVID-19 immunization. The patient's medical history included hypertension, hyperkeratosis lenticularis perstans, osteoarthritis, allergies to medication, food, or other products, and COVID-19 diagnosed prior to vaccination. The patient's concomitant medications were not reported. The patient was not tested for COVID-19 since vaccination. Patient was not pregnant at the time of vaccination. On 21Jan2021, 05:00, the patient experienced heavy headed (not headache), malaise and chills. Patient felt like her 2nd day of COVID, afebrile. The patient received ibuprofen (ADVIL) 600 mg for the events. The outcome of the events was recovered on an unspecified date. The events were non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest discomfort, Dizziness, Eye discharge, Eye irritation
Clinical narrative: Dizziness; nausea; headache; constant eye and nose drain; constant eye and nose drain; burning eye and nose; burning eye and nose; weakness; tiredness; sore lips and throat; sore lips and throat; sore on tongue; chest tightness; This is a spontaneous report from a contactable consumer reporting for herself.  A 62-year-old female patient received the 1st dose of bnt162b2 (BNT162B2) at single dose at left arm on 14Jan2021 11:30 for Covid-19 immunisation, administered at hospital.  Medical history included hypertension, high cholesterol, diabetes mellitus, allergies penicillin. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication within 2 weeks of vaccination included atenolol (manufacturer unknown), losartan (manufacturer unknown), atorvastatin (manufacturer unknown), hydrochlorothiazid (manufacturer unknown). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Jan2021 07:00 the patient experienced dizziness, nausea, headache, constant eye and nose drain, burning eye and nose, weakness, tiredness, sore lips and throat, sore on tongue, chest tightness. The patient underwent lab tests and procedures which included Sars-cov-2 nasal swab test: negative on 19Jan2021. The outcome of all events was not recovered as all ongoing now for 1 week. The events were considered non serious.  Information on the lot/batch number has been requested.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Glossodynia, Headache, Lip pain, Nasal discomfort
Clinical narrative: Dizziness; nausea; headache; constant eye and nose drain; constant eye and nose drain; burning eye and nose; burning eye and nose; weakness; tiredness; sore lips and throat; sore lips and throat; sore on tongue; chest tightness; This is a spontaneous report from a contactable consumer reporting for herself.  A 62-year-old female patient received the 1st dose of bnt162b2 (BNT162B2) at single dose at left arm on 14Jan2021 11:30 for Covid-19 immunisation, administered at hospital.  Medical history included hypertension, high cholesterol, diabetes mellitus, allergies penicillin. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication within 2 weeks of vaccination included atenolol (manufacturer unknown), losartan (manufacturer unknown), atorvastatin (manufacturer unknown), hydrochlorothiazid (manufacturer unknown). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Jan2021 07:00 the patient experienced dizziness, nausea, headache, constant eye and nose drain, burning eye and nose, weakness, tiredness, sore lips and throat, sore on tongue, chest tightness. The patient underwent lab tests and procedures which included Sars-cov-2 nasal swab test: negative on 19Jan2021. The outcome of all events was not recovered as all ongoing now for 1 week. The events were considered non serious.  Information on the lot/batch number has been requested.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative
Clinical narrative: Dizziness; nausea; headache; constant eye and nose drain; constant eye and nose drain; burning eye and nose; burning eye and nose; weakness; tiredness; sore lips and throat; sore lips and throat; sore on tongue; chest tightness; This is a spontaneous report from a contactable consumer reporting for herself.  A 62-year-old female patient received the 1st dose of bnt162b2 (BNT162B2) at single dose at left arm on 14Jan2021 11:30 for Covid-19 immunisation, administered at hospital.  Medical history included hypertension, high cholesterol, diabetes mellitus, allergies penicillin. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication within 2 weeks of vaccination included atenolol (manufacturer unknown), losartan (manufacturer unknown), atorvastatin (manufacturer unknown), hydrochlorothiazid (manufacturer unknown). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Jan2021 07:00 the patient experienced dizziness, nausea, headache, constant eye and nose drain, burning eye and nose, weakness, tiredness, sore lips and throat, sore on tongue, chest tightness. The patient underwent lab tests and procedures which included Sars-cov-2 nasal swab test: negative on 19Jan2021. The outcome of all events was not recovered as all ongoing now for 1 week. The events were considered non serious.  Information on the lot/batch number has been requested.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Feeling abnormal, Pain
Clinical narrative: Fever just measured at 100.3F; feeling pretty miserable; Joint pain; aches; chills; This is a spontaneous report from a contactable other healthcare professional (patient). A 38-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL3249), via an unspecified route of administration on 21Jan2021 10:15 at SINGLE DOSE for COVID-19 immunisation. The vaccine location was at the right arm and patient received the first dose of the vaccine. The patient was administered COVID-19 vaccine at the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included diagnosis of COVID-19 prior to vaccination, chronic sinusitis, anxiety, depression, and attention deficit hyperactivity disorder (ADD). The patient had no allergies to medications, food, or other products. Concomitant medications included sertraline hydrochloride (ZOLOFT), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), clarithromycin, and clonazepam. The patient stated, "I have tested covid + the day after Thanksgiving and this feels just like it minus the respiratory symptoms. Pretty much all the signs of an immune response. Fever just measured at 100.3F. I'm feeling pretty miserable. Joint pain, aches, chills." The events started on 22Jan2021 at 05:00 AM. The reporter considered the events as non-serious. There was no treatment received for the events. It was also reported that since the vaccination, the patient has not been tested for COVID-19. The patient underwent lab test and procedure on 27Nov2020 which included COVID test which showed positive. The patient had not yet recovered from the events "Fever just measured at 100.3F. I'm feeling pretty miserable. Joint pain, aches, chills."
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever just measured at 100.3F; feeling pretty miserable; Joint pain; aches; chills; This is a spontaneous report from a contactable other healthcare professional (patient). A 38-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL3249), via an unspecified route of administration on 21Jan2021 10:15 at SINGLE DOSE for COVID-19 immunisation. The vaccine location was at the right arm and patient received the first dose of the vaccine. The patient was administered COVID-19 vaccine at the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included diagnosis of COVID-19 prior to vaccination, chronic sinusitis, anxiety, depression, and attention deficit hyperactivity disorder (ADD). The patient had no allergies to medications, food, or other products. Concomitant medications included sertraline hydrochloride (ZOLOFT), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), clarithromycin, and clonazepam. The patient stated, "I have tested covid + the day after Thanksgiving and this feels just like it minus the respiratory symptoms. Pretty much all the signs of an immune response. Fever just measured at 100.3F. I'm feeling pretty miserable. Joint pain, aches, chills." The events started on 22Jan2021 at 05:00 AM. The reporter considered the events as non-serious. There was no treatment received for the events. It was also reported that since the vaccination, the patient has not been tested for COVID-19. The patient underwent lab test and procedure on 27Nov2020 which included COVID test which showed positive. The patient had not yet recovered from the events "Fever just measured at 100.3F. I'm feeling pretty miserable. Joint pain, aches, chills."
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Fatigue, Headache, Neck pain
Clinical narrative: neck, back & shoulder pain; neck, back & shoulder pain; neck, back & shoulder pain; headache; exhaustion; This is a spontaneous report from a contactable consumer. A 58-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL3247, expiry date not reported), via an unspecified route of administration on 20Jan2021 14:30 at a single dose in the left arm for covid-19 immunization. Medical history included arthritis, high cholesterol, high blood pressure, allergies to food (oats, corn, chocolate), and thyroid (thyroid disorder). The patient was not pregnant at the time of the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included meloxicam (MOBIC), and other medications the patient received within 2 weeks of vaccination for blood pressure, thyroid, and cholesterol. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 21Jan2021 15:00, patient experienced neck, back and shoulder pain, headache, exhaustion, started 24 hr (hour) after vaccine and resolved in 12 hr (hour). The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). No treatments received in response to the events reported. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events neck, back and shoulder pain, headache, and exhaustion was recovered on 22Jan2021 02:00; reported as resolved in 12 hr.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Flushing, Headache, Hypersomnia
Clinical narrative: Chills; fever; headache; pallor then flushing; pallor then flushing; nausea; malaise; muscle aches; extreme fatigue; slept for 16 hours straight; This is a spontaneous report from a contactable nurse reporting for herself. A 55-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular on the right arm on 21Jan2021 08:30 at a SINGLE DOSE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included hypertension from an unknown date and unknown if ongoing. Concomitant medication included hctz (HCTZ). The patient received the first dose last 30Dec2020. On 21Jan2021 09:30 PM, the patient experienced chills, fever, headache, pallor then flushing, nausea, malaise, muscle aches, extreme fatigue and she slept for 16 hours straight. No treatment was received for the events. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Nausea, Pallor, Pyrexia
Clinical narrative: Chills; fever; headache; pallor then flushing; pallor then flushing; nausea; malaise; muscle aches; extreme fatigue; slept for 16 hours straight; This is a spontaneous report from a contactable nurse reporting for herself. A 55-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular on the right arm on 21Jan2021 08:30 at a SINGLE DOSE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included hypertension from an unknown date and unknown if ongoing. Concomitant medication included hctz (HCTZ). The patient received the first dose last 30Dec2020. On 21Jan2021 09:30 PM, the patient experienced chills, fever, headache, pallor then flushing, nausea, malaise, muscle aches, extreme fatigue and she slept for 16 hours straight. No treatment was received for the events. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Flank pain, Headache
Clinical narrative: Muscle aches; Back/flank pain; Back/flank pain; Headache; Low grade fever; Joint pain; Chills; This is a spontaneous report from a contactable nurse (patient). A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), intramuscular on the left arm, on 20Jan2021 10:45 at single dose for covid-19 immunisation.  The first dose was received on 01Jan2021 09:00, intramuscular on the left arm . Medical history included asthma, depression, and in the midst of getting diagnosed with Sjogerns.  Patient was not pregnant at the time of vaccination. Concomitant medication included spironolactone, bupropion, fexofenadine hydrochloride (ALLERFEX) and hair vitamins. The patient experienced muscle aches, back/flank pain, headache, low grade fever, joint pain, and chills on 20Jan2020 17:30. No treatment was received and patient was recovering from the events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The events were considered non-serious.  No follow-up attempts are possible. Information on batch/lot number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Muscle aches; Back/flank pain; Back/flank pain; Headache; Low grade fever; Joint pain; Chills; This is a spontaneous report from a contactable nurse (patient). A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), intramuscular on the left arm, on 20Jan2021 10:45 at single dose for covid-19 immunisation.  The first dose was received on 01Jan2021 09:00, intramuscular on the left arm . Medical history included asthma, depression, and in the midst of getting diagnosed with Sjogerns.  Patient was not pregnant at the time of vaccination. Concomitant medication included spironolactone, bupropion, fexofenadine hydrochloride (ALLERFEX) and hair vitamins. The patient experienced muscle aches, back/flank pain, headache, low grade fever, joint pain, and chills on 20Jan2020 17:30. No treatment was received and patient was recovering from the events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The events were considered non-serious.  No follow-up attempts are possible. Information on batch/lot number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: my heart started racing; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration in Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient took it now and was not sure whether to take the second shot or not, the seconds shot due next Friday. And the day after the patient took it (Jan2021), the patient's heart started racing. "It's did that, I mean it's still doing that off and on is that one of the side effects. Cause I saw but I thought it was immediately after." Outcome of the event was unknown.   Information on the lot/ batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable female consumer (patient) from a Pfizer-sponsored program COVAX US Support.  A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient tested covid positive on 07Jan2021, after she got her first dose of pfizer covid vaccine. The outcome of the event was unknown.   Information on the Lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Sore throat; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283 and expiry date: unknown), via an unspecified route of administration on 15Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient stated that the day after he got the injection, he started to get a sore throat on 16Jan2021. He assumed it was a side effect and the sore throat has not gotten better. It was possibly somewhat worse and was debilitating. He wanted to know if this was a side effect that will go away and what he can do to help it go away. Outcome of the event was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: fever; sore arm; headache; fatigue; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer sales representative. A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history  and concomitant medications were not reported. The patient had the following symptoms after vaccination: some fever, sore arm, slight mild headache and fatigue. The outcome of the events was unknown.  No follow-up attempts are possible; Information about batch/lot number cannot be obtained. No further information is expected.